Skip to main content
Equibles

Swiss National Bank

Bank

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1582202 ZURICH, V8
Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5,539,200
+$1,690,872 QoQ
Shares Held
320,000
+3.4% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 311 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. AMRX ranks #12 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 4,121,700 $139,643,196
2 ZTS
Zoetis Inc.
 1,186,032 $85,228,259
3 UTHR
UNITED THERAPEUTICS Corp
 111,255 $60,281,296
4 NBIX
Neurocrine Biosciences Inc
 268,900 $45,320,406
5 VTRS
Viatris Inc
 2,336,402 $37,102,063
6 ELAN
Elanco Animal Health Inc
 1,001,992 $24,659,023
7 ALKS
Alkermes plc.
 316,900 $16,605,560
8 LNTH
Lantheus Holdings, Inc.
 130,654 $14,494,754

All Filings in AMRX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,539,200 320,000
2026-03-31 $3,848,328 309,600
2025-12-31 $3,900,960 309,600
2025-09-30 $3,040,037 303,700
2025-06-30 $2,422,146 299,400
2025-03-31 $2,263,438 270,100
2024-12-31 $2,170,080 274,000
2024-09-30 $2,014,272 242,100
2024-06-30 $1,537,335 242,100
2024-03-31 $1,467,126 242,100
2023-12-31 $1,291,089 212,700
2023-03-31 $295,375 212,500
2022-12-31 $472,824 237,600
2022-09-30 $463,792 229,600
2022-06-30 $730,128 229,600
2022-03-31 $957,432 229,600
2021-12-31 $1,013,085 211,500
2021-09-30 $1,129,410 211,500
2021-06-30 $1,082,880 211,500
2021-03-31 $1,460,410 217,000
2020-12-31 $991,690 217,000
2020-09-30 $841,960 217,000
2020-06-30 $925,820 194,500
2020-03-31 $724,188 208,100